Flags of India and Israel (Photos: Pexels)
India’s Sun Pharma and Israel’s Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis. The studies, featured in the peer-reviewed Osteoarthritis and Cartilage journal, show that a single injection of MM-II can provide long-lasting pain relief and protect cartilage.
The drug, developed in Israel and supported by Sun Pharma, recently received Fast Track Designation from the US FDA. New findings will be presented at the OARSI 2025 World Congress.
Australia's High Commissioner to India, Philip Green OAM, called Yoga one of India's gifts to…
The Bharat Sanchar Nigam Limited (BSNL) has announced the soft launch of BSNL Quantum 5G…
The Indian Embassy in Iran has said that the embassy will make efforts to evacuate…
India's gross direct tax collections for the financial year 2025-26 rose by 4.86 per cent…
Russian President Vladimir Putin has said that Moscow is not seeking Ukraine's unconditional surrender, but…
Extending his greetings on the 11th International Day of Yoga, Lok Sabha speaker Om Birla…
